
Ticaron 90mg Tablet
Marketer
Camrut Pharma
Salt Composition
Ticagrelor (90mg)
Overview Ticaron 90mg Tablet
Cardiogard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thereby lowering the risk of stroke or heart attack in patients with cardiac conditions. Cardiogard 90mg is also indicated for individuals recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or following coronary stenting. It lessens the likelihood of subsequent cardiac events, including further heart attacks, strokes, or clot formation within stents. Concomitant use with aspirin, another antiplatelet medication, will be prescribed by your physician. Cardiogard 90mg can be ingested with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as discontinuation may elevate the risk of recurrent heart attack or stroke. The most prevalent adverse effect is increased bleeding tendency; injuries may bleed more profusely and for longer periods. While usually mild and self-limiting, prolonged or excessive bleeding should be reported. Some patients experience mild shortness of breath, which typically subsides with ongoing treatment; however, worsening or persistent dyspnea warrants medical attention. Cardiogard 90mg is contraindicated in individuals with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor prior to commencing treatment.
Uses of Ticaron 90mg Tablet
Cardiovascular event prophylaxis
Major Benefits of Ticaron 90mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticaron 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ticaron 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticaron 90mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticaron 90mg Tablets can be consumed with or without food, however, consistent timing is recommended.
How Ticaron 90mg Tablet works:
Ninetieth-milligram Ticaron tablets are antiplatelet agents. Their mechanism involves inhibiting platelet aggregation, thus reducing the risk of dangerous thrombus development. This, in turn, diminishes the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Ticaron 90mg Tablets requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Ticaron 90mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticaron 90mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticaron 90mg tablets.
KidneySAFE IF PRESCRIBED
Ticaron 90mg tablets pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Data regarding Ticaron 90mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Ticaron 90mg tablets; dosage modification may be necessary. Severe liver disease contraindicates the use of Ticaron 90mg tablets; physician consultation is advised.
What if you forget to take Ticaron 90mg Tablet :
Should you forget a Ticaron 90mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticaron 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
